Investment Type: Venture Capital
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| 15.10.2025 | Mission Th... | missiontherapeutics.com | $191.92M | United Kin... |
Mentions in press and media 3
| Date | Title | Description |
| 17.07.2026 | DIMERIX EXPANDS PIPELINE WITH ACQUISITION OF PHASE 2 READY ASSET FOR ACUTE KIDNEY INJURY | Highlights Dimerix acquires Phase 2-ready asset, DMX-652 - with potential for rapid advancement into a Phase 2 clinical study under an open US Investigational New Drug (IND) application, with initial focus on acute kidney injury (AKI) DMX-6... |
| 15.10.2025 | Mission Therapeutics Raises $13.3M in Funding | Mission Therapeutics, a Cambridge, UK-based clinical-stage biotech developing first-in-class therapeutics that promote cell and organ health by enhancing mitophagy, raised $13.3m in funding. The financing was led by current investors Pfizer... |
| 18.02.2014 | Novimmune announces closing of CHF 60 million financing |